2026³â 06¿ù 01ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

HOLLYWOOD, FLA. -- The Additive Manufacturer Green Trade Association (AMGTA) today announced that EOS has elevated its longstanding participation in t

AI-enhanced intellectual property search solution simplifies complex research and expands curated content access.
´º½ºÀÏÀÚ: 2026-02-23

COLUMBUS, OHIO -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced complete functionality for CAS IP Finder™, powered by STN™. CAS STNext® customers can now access the full intellectual property search solution across all search methods, expanded content collections, and advanced analysis tools.

Patent volume continues to grow, and scientific disciplines are increasingly interconnected, making intellectual property research more complex and increasing the risk of missed prior art. Organizations traditionally chose between empowering specialized searchers with comprehensive tools or providing limited capabilities to broader teams. CAS IP Finder eliminates that compromise by providing flexible access points that connect users of all experience levels to curated content and precise search tools.

“As scientific and patent data grow in complexity, organizations need IP search solutions that enable access across entire teams,” said Manuel Guzman, President, CAS. “CAS IP Finder enables broader participation in IP research while maintaining the depth and accuracy that complex patent work demands, supporting faster, evidence-based decisions.”

Easier access to comprehensive databases without sacrificing precision

CAS IP Finder maintains access to more than 100 scientific, patent, and non-patent literature databases that have been the foundation of STN for decades. Now, users can search this wealth of data without command-line knowledge while preserving the precision IP professionals require. New capabilities include:

· An intuitive query builder enabling high-quality searches without traditional learning curves.
· Proprietary AI-enhanced exploratory search that analyzes text using machine learning and natural language processing.
· Expanded life sciences content embedded specifically to help IP professionals find critical information in complex datasets.
· Interactive visualization tools for exploring patterns in large datasets.
· Enhanced reporting features with customizable keyword highlighting and formatting options.

Among these capabilities, proprietary exploratory search stands out as a unique advancement in IP research, analyzing text input to identify relevant patents and non-patent documents, detecting key terms, and suggesting refinements that improve relevance without requiring specialized syntax knowledge. Patent examiners have adopted this approach because it delivers insights previously unavailable through conventional searches.

“The challenge was maintaining the precision and depth of CAS STNext while eliminating the traditional command-line barrier,” said Tim Wahlberg, Chief Product Officer, CAS. “Our proprietary exploratory search uses machine learning trained on the CAS Content Collection to deliver insights that patent examiners are now relying on. We have made complex IP research accessible without compromising accuracy.”

The solution also addresses specific needs in pharmaceutical and biotechnology research. The CAS Bioactivity file, curated by CAS scientists, provides normalized structure-activity relationships, ADME, and toxicity data structured specifically to support patent research workflows. This targeted approach helps researchers pinpoint critical information that would be difficult to locate through conventional methods, reducing risk in drug discovery and development.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026
LG Electronics Presents Hybrid Emergency Call Solution at 5GAA in Sweden
AI Factory Market Enters Industrialization Era as Five Dynamics Redefine AI Infrastructure in 2026
Mundipharma Reports Positive Phase III ReSPECT Topline Results of REZZAYO¢ç for Preventing Invasive Fungal Diseases in HSCT
LTM Launches BlueVerse¢â Studio as a Hub for Enterprise Agentic AI Adoption
Southeast Asia smartphone market shipments decline 9% in 1Q26
GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for FDA Fast Track MRI Contrast Agent Innovation

 

NIQ Launches Commerce Lab to Build the Data and Measurement Layer for ...
First Enterprise Quantum Computer Purchase in Japan: IQM to Deploy Sys...
As Network Security Strengthens, Criminals Accelerate Shift to AI-Enab...
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic The...
NetApp Strengthens its Collaboration with Google Cloud on Unified Goog...
Diligent Unveils AI Board Member and Agentic GRC Workforce at Elevate ...
AI Demand Sparks Q1 Double-Digit Growth in Asia Pacific¡¯s Technology ...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ù±药...
'º£³×ÀÍ' Áß¹® Ç¥±â 宝Ò¬ìÌ, 'À̺ñÁî: ÀÌÁö' Áß¹® Ç¥±â æ¶币òª...
¿¡³ÊÀÌÀ¯ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ Alliuv ä¹备: ä¹êó备, ¾Ë¶ã Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØ ä¹ì³ÜØ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..